The Dow Chemical Company (NYSE: DOW) continues to drive growth and demonstrate its strong patent position through a number of licensing programs and technologies that are gaining momentum on a global scale and providing customers with next-generation industry standards and solutions.
Dow PP Licensing & Catalysts
The UNIPOL™ Polypropylene Process for manufacturing polypropylene (PP) resins, for example, brings the power of Dow’s market-leading gas-phase process technology with its high quality SHAC™ and CONSISTA™ Catalyst and Donor systems to resin producers worldwide.
Capitalizing on strong growth in polypropylene demand, Dow has signed four licensees in 2012, which would create another nearly 1,500 KTA polypropylene capacity by 2015. Resins produced by UNIPOL Polypropylene Technology from Dow account for 17 percent of global polypropylene output and enable producers to make resins that improve the performance of other types of plastics, or to offer polypropylene resins with better clarity, stiffness and impact strength.“The decision to grow Dow Polypropylene Licensing & Catalysts despite the Company’s sale of its global polypropylene resins business in 2011 was the right decision,” said Tracy Cleckler, global commercial director, Dow Plastics Licensing & Catalysts. “We have reached record sales and EBITDA in 2012, while maintaining our 100 percent repurchase rate on catalysts for new licensees since 2000, which demonstrates how our innovation strategy is meeting market needs for operational reliability and new levels of advanced product capabilities.” The business unit has also broadened its innovation reach beyond its UNIPOL PP technology, including the licensing of its catalyst technology to producers in liquid loop processes. Earlier this year, Dow signed an agreement with W.R. Grace & Co. to develop new catalysts for liquid-phase polypropylene production using one of Dow’s non-phthalate internal donor technologies. Thin Foamed Polyethylene Films Providing packaging manufacturers with another option to enhance their sustainability efforts, Dow and MuCell Extrusion LLC recently announced the two companies will exclusively license Dow’s thin foamed films patent family. This partnership connects Dow’s formulation expertise with MuCell’s strong process background for a bundled one-source proposition that will significantly streamline the development process.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts